Endogenously synthesized liver triglyceride (TG) is secreted into the blood in the form of TG-rich very low density lipoprotein (VLDL) containing lipids and lipoproteins such as phospholipids, cholesterol ester, and apolipoprotein B (apoB). It is known that microsomal TG transfer protein (MTP) in the liver catalyzes the assembly of TG, the conversion of apoB into VLDL, and the secretion of VLDL into the blood.
Endogenously synthesized liver triglyceride (TG) is secreted into the blood in the form of TG-rich very low density lipoprotein (VLDL) containing lipids and lipoproteins such as phospholipids, cholesterol ester, and apolipoprotein B (apoB). It is known that microsomal TG transfer protein (MTP) in the liver catalyzes the assembly of TG, the conversion of apoB into VLDL, and the secretion of VLDL into the blood. [1] [2] [3] Recently, it was reported that calcium antagonists inhibit the secretion of VLDL from rat hepatocytes into the blood. [4] [5] [6] From these results, [4] [5] [6] it could be speculated that MTP activity might be stimulated by the increase of intracellular Ca 2ϩ . A few studies have reported that the calcium ionophore (A23187) and thapsigargin, an inhibitor of Ca 2ϩ -ATPase in the endoplasmic reticulum (ER), inhibit VLDL secretion by hepatocytes. 7, 8) At present, despite many studies on MTP activity, the role of Ca 2ϩ on MTP activity in hepatocytes is poorly understood, and the inhibition of MTP activity is associated with the suppression of hypertriglyceridemia and atherosclerosis. In recent, in another experiment, we found that MTP activity was relatively higher under high Ca 2ϩ level (10.1Ϯ1.8 mM/protein-mg) than under low Ca 2ϩ level (6.2Ϯ1.9 mM/protein-mg) in liver tissues, and its activity was about 2-fold higher than under low Ca 2ϩ level, and had a relative association with hyperlipoproteinemia. It is inferred that MTP activity may have a correlation with Ca 2ϩ level in the liver. Accordingly, we investigated the effects of Ca 2ϩ on MTP activity in hepatocytes, our data demonstrate that MTP activity may be activated by Ca 2ϩ and calmodulin, and may inhibit hypertriglyceridemia by decreasing the level of Ca 2ϩ in hepatocytes.
MATERIALS AND METHODS

Materials
Hanks' balanced salts (HBSS) buffer (without calcium chloride, magnesium sulfate, and sodium bicarbonate) for collagenase perfusion and Williams' medium E (with L-glutamine but without sodium bicarbonate) for hepatocytes culture were purchased from Sigma (St. Louis, MO, U.S.A.). MTP assay kits were obtained from Calbiochem ® (an affiliate of Merck KGaA, Darmstadt, Germany). Lipid assay kits were obtained from Nissui Pharmaceutical (Tokyo, Japan). Collagenase (type IV) and other chemical reagents were obtained from Sigma (St. Louis, MO, U.S.A.).
Preparation of Hepatocytes and Cell Culture Freshly isolated hepatocytes were prepared from adult male Sprague-Dawley rats weighing between 200 and 250 g. The hepatocytes were isolated by the collagenase-liver perfusion method of Berry and Friend. 9) Hepatocytes viability was assessed by trypan blue exclusion. Cell viability assessed by trypan blue exclusion averaged 95%. Hepatocytes with 95% viability were washed three times with washing buffer [Williams' medium E, 23.8 M NaHCO 3 , 0.5 mM dexamethasone, and 15 mM HEPES, pH 7.4 supplemented with 1000 U/l penicillin, 1 mg/l streptomycin, 1 mM insulin]. Hepatocytes (10 6 cells/well) suspended in culture medium (washing buffer supplemented with 10% fetal bovine serum) were placed in culture dishes (FALCON ® , Becton Dickinson and Company, Franklin Lakes, NJ, U.S.A.), and were incubated at 37 ЊC under 5% CO 2 for 3 h. Monolayers were washed twice with culture medium, and supplemented with 3 ml of fresh culture medium. To investigate the effects of calcium on MTP activity, hepatocytes (10 6 cells/well) were incubated at 37 ЊC for 6 h with or without the testing substances such as CaCl 2 , EDTA, and A23187 in the absence of exogenous calmodulin. A23187 was dissolved in 0.001% of ethanol. The incubation was stopped on ice. Hepatocytes were used for assay of MTP, TG, and Ca 2ϩ , and culture medium was used for determination of lipids.
Measurements of Calcium Effects on MTP Activity MTP activity was determined using a commercial kit based on the MTP-mediated transfer of a self-quenched fluorescent neutral lipid from the core of a donor molecule to an acceptor molecule (Calbiochem ® , Germany). Hepatocytes treated with CaCl 2 , EDTA, or A23187 were sonicated on ice with 2 bursts for 10 s in an ultrasonic homogenizer (Bandelin, HD2070, Germany) used at 30% power. To determine MTP activity, hepatocellular lysates (200 mg-protein), the MTP source, were incubated with gentle shaking for 2 h at 37 ЊC in the presence of 10 ml of donor molecule containing a fluorescent neutral lipid and 10 ml of acceptor molecule as described in manual of MTP assay kits. MTP activity was determined by measuring fluorescence at 535 nm with excitation at 465 nm. Because a fluorescent compound A23187 produce emission at a single maximum located at 437 nm, 10) A23187 does not affect on MTP fluorescence. MTP activity was calculated after subtracting the value of the blank fluorescence from each sample by using a standard curve.
Measurements of Calmodulin and W-7 Effects on MTP Activity To investigate the effects of exogenous calmodulin on MTP activity, control hepatocytes, did not treated with CaCl 2 , EDTA, and A23187, were lysised by sonicating as described above. Hepatocellular lysates (200 mgprotein) were incubated for 2 h at 37 ЊC with or without various concentrations of calmodulin, CaCl 2 (100 mM), or W-7 (25 mM) in the presence of 10 ml of donor molecular containing a fluorescent neutral lipid and 10 ml of acceptor molecule. MTP activity was determined as described above. To determine the effect of both Ca 2ϩ and calmodulin on MTP activity, because 0.4 mg of calmodulin and 100 mM of CaCl 2 are required to reach a half-maximal stimulation of enzymes such as phosphodiesterase activity, [11] [12] [13] [14] we used 100 mM of CaCl 2 and 0.4 mg of calmodulin. And, to determine the effect of W-7 on MTP activity, we used 25 mM of W-7 having selective binding inhibitory effect to calmodulin.
Determination of TG Level in Hepatocytes Total lipids in hepatocytes were extracted with chloroform/ methanol (2 : 1, v/v) containing 0.001% butylated hydroxytoluene and 0.1 mM tocopherol and neutral lipids were separated on a silicic acid column (0.5 cmϫ12 cm) by eluting with hexane/diethylether (7 : 3, v/v). TG level was determined using an enzymatic assay kit (Nissui Pharmaceutical, Tokyo, Japan) after sonicating neutral lipids with 5 mM deoxycholate.
Determination of Ca 2ϩ in Hepatocytes The Ca 2ϩ level in hepatocytes was determined by the method of Moore. 15) To estimate Ca 2ϩ in hepatocytes, all medium were removed first then the hepatocytes were suspended in distilled water. Hepatocellullar lysates were prepared as described above. Hepatocellular lysates were dried overnight at 95 ЊC, and then ashed for 72 h at 660 ЊC. The ashed samples were collected in 0.1 N HCl solution containing 0.1% LaCl 3 . Ca 2ϩ was assayed with a Ca 2ϩ assay kits (Iatron Laboratories, Tokyo, Japan).
Determination of Lipid Levels in Hepatocytes Culture Medium Lipids in hepatocyte culture medium were determined by using assay kits (Nissui Pharmaceutical, Tokyo, Japan). TG was determined by enzymatic method using lipoprotein lipase, glycerol kinase, and glycerol peroxidase. Total cholesterol was determined by enzymatic method using cholesterol esterase, cholesterol oxidase, and peroxidase. High density lipoprotein (HDL)-cholesterol was determined by enzymatic method after precipitation of VLDL with the complex of sodium phosphotungstic acid and MgCl 2 . Protein contents were determined by the method of Lowry.
16)
Statistical Analysis Differences between two groups were analyzed using the Student's t-test with correction for different variances when appropriate.
RESULTS
The Activity of MTP Is Increased by Ca
2؉
When hepatocytes (10 6 cells/well) were incubated at 37 ЊC for 6 h in physiological culture medium (Williams' medium E) containing 1.8 mM CaCl 2 , MTP activity was 2649Ϯ202 nM/protein-mg, control (Fig. 1A) . However, when hepatocytes (10 6 cells/well) were incubated at 37 ЊC for 6 h in the presence of various concentrations of CaCl 2 (10, 50, 100 mM), MTP activity was increased by CaCl 2 (10, 50, 100 mM) from 2649Ϯ202 nM/protein-mg, control, to 3639Ϯ153 nM/proteinmg by 100 mM CaCl 2 (Fig. 1A) . These results suggest that MTP activity more increases in high exogenous Ca 2ϩ concentration than in intact hepatic total Ca 2ϩ level (0.40Ϯ 0.01 mM/protein-mg) and physiological Ca 2ϩ concentration (1.8 mM) containing in the media. If Ca 2ϩ in hepatocytes involves in the activation of MTP, a Ca 2ϩ receptor calmodulin might increase MTP activity. Intracellular calmodulin plays important roles in many physiological processes where calcium ion involved. So, we investigated whether calmodulin is associated with the activation of MTP. Exogenous calmodulin (0.1, 0.2, 0.4 mg) increased MTP activity from 2649Ϯ 202 nM/protein-mg, control, to 3564Ϯ351 nM/protein-mg in a dose-dependent manner (Fig. 1B) .
The Activity of MTP Is Decreased by EDTA and W-7 MTP activity (3639Ϯ107 nM/protein-mg) increased by exogenous CaCl 2 (100 mM) was inhibited to 2438Ϯ58 nM/ protein-mg in the presence of EDTA (2 mM) ( Fig. 2A) . This means that EDTA decreases MTP activity by chelating exogenous CaCl 2 (100 mM) and 1.8 mM CaCl 2 in culture medium. The 100 nM of A23187 is known to increase Ca 2ϩ level, and inhibit the secretion of TG and apoB, 8) which means that A23187 (100 nM) may inhibit MTP activity. However, when hepatocytes were incubated at 37 ЊC for 6 h in the presence of A23187 (100 nM), hepatocellular total Ca 2ϩ level (0.90Ϯ0.38 mM/mg-protein) and MTP activity (3344Ϯ 203 nM/protein-mg) were higher than those (Ca 2ϩ level, 0.40Ϯ0.01 mM/protein-mg; MTP activity, 2649Ϯ202 nM/protein-mg) in the absence of A23187 (Figs. 2B, 3A) . On the other hand, when both A23187 (100 nM) and EDTA (2 mM) were simultaneously added to hepatocytes (10 6 cells/well), MTP activity (3344Ϯ203 nM/protein-mg) increased by A23187 (100 nM) was significantly decreased to 2365Ϯ 67 nM/protein-mg ( Fig. 2A) , and hepatocellular total Ca 2ϩ level (0.90Ϯ0.38 mM/mg-protein) was decreased to 0.28Ϯ 0.17 mM/protein-mg (Fig. 3A) . Furthermore, the simultaneous presence of exogenous calmodulin (0.4 mg) and CaCl 2 (100 mM) potently activated MTP (Fig. 2B) . It seems that Ca 2ϩ /calmodulin complex might be involved in MTP activation, otherwise its activity should not be inhibited by W-7 (K i =25 mM), a Ca 2ϩ antagonist, 17) in the simultaneous presence of exogenous calmodulin and CaCl 2 . W-7 (25 mM) significantly inhibited the MTP activity (3447Ϯ85 nM/protein-mg) increased in the presence of exogenous calmodulin (0.4 mg) and CaCl 2 (100 mM) to 2170Ϯ390 nM/protein-mg (Fig. 2B) .
Changes in the Levels of Ca 2؉ and TG in Hepatocytes When hepatocytes (10 6 cell/well) were treated with A23187, total Ca 2ϩ level (0.90Ϯ0.38 mM/protein-mg) in hepatocytes was higher than that (0.40Ϯ0.01 mM/protein-mg) in control (Fig. 3A) . These results suggest that the level (0.40Ϯ 0.01 mM/protein-mg) of Ca 2ϩ in hepatocytes under the condition of physiological culture is increased about 2-fold (0.90Ϯ0.38 mM/protein-mg) by the addition of A23187. On the other hand, EDTA decreased the Ca 2ϩ level elevated by the addition of A23187 (Fig. 3A) . These results reflect that hepatic Ca 2ϩ elevated by A23187, in which MTP activity was increased ( Fig. 2A) , might be explained in the same manner as MTP activity increased by various exogenous CaCl 2 concentrations (Fig. 1A) . TG level (3.13Ϯ0.71 mg/ protein-mg) in hepatocytes was also increased by addition of A23187 as compared with that (0.36Ϯ0.09 mg/protein-mg) of control, in the absence of A23187 (Fig. 3B) . These results are in accord with the facts that Ca 2ϩ accumulates hepatocellular TG, 18) and MTP activity increases due to an increased TG level in hepatocytes. 19) These phenomena would lead to a release of TG-rich VLDL from hepatocytes. Therefore, we determined the level of culture medium lipids released by hepatocytes.
TG Release Resulted from Increased MTP Activity We determined the level of TG, total cholesterol (TC), and HDL-cholesterol. The level (95.0Ϯ1.0ϫ10 2 ng/protein-mg) of TG in culture medium from hepatocytes incubated with A23187 (100 nM), increased MTP activity, was higher than that (67.0Ϯ0.5ϫ10 2 ng/protein-mg) in control (Fig. 4A ). When hepatocytes (10 6 cells/well) were incubated with A23187 (100 nM) and EDTA (2 mM) at 37 ЊC for 6 h, the level of TG released into culture medium was decreased to 1420 Vol. 28, No. 8 
57.0Ϯ1.0ϫ10
2 ng/protein-mg (Fig. 4A) . This result suggests that A23187 may stimulate the secretion of TG from hepatocytes by increasing MTP activity (Figs. 2A, 3B ). When the hepatocytes (10 6 cells/well) were incubated with A23187 (100 nM) at 37 ЊC for 6 h, even though the change of TC level in culture medium was not significant, a little was increased as compared with that of control (Fig. 4B) . And then HDLcholesterol in culture medium was not significantly changed as compared with that of control (Fig. 4C ). However, the TC level was decreased, and HDL-cholesterol was not decreased in the presence of EDTA (Figs. 4B, C) . These results suggest that A23187 does not release HDL-cholesterol from hepatocytes but release lipoprotein (i.e., VLDL) containing TG, and cholesterol. The increase in the ratio of TG to HDL-cholesterol is known to increase the risk of atherosclerosis. 20) The ratio of TG to HDL-cholesterol was potently increased from 8.1Ϯ0.4, control, to 13.4Ϯ0.2 by incubation with A23187 (100 nM) (Fig. 4D) . However, the ratio increased by A23187 was returned to the level (8.3Ϯ0.2) of control in the presence of EDTA.
DISCUSSION
Here, we reveal the possible role of Ca 2ϩ on MTP activity. Exogenous CaCl 2 increased MTP activity in hepatocytes in a dose-dependent manner (Fig. 1A) . When the total Ca 2ϩ level in intact hepatocytes (10 6 cells) is 0.40Ϯ0.01 mM/protein-mg, the hepatic MTP activity is 2649Ϯ22 nM/protein-mg in the absence of exogenous CaCl 2 , control (Fig. 1A) . However, the MTP activity (2649Ϯ22 nM/protein-mg) in intact hepatocytes was increased to 3639Ϯ107 nM/protein-mg in the presence of exogenous CaCl 2 (100 mM) (Fig. 1A) . This suggests that MTP activity is directly increased by exogenous CaCl 2 . At present, whether exogenous CaCl 2 was used as a source of hepatocellular Ca 2ϩ to increase MTP activity is not known. Because hepatocytes were incubated in the presence of insulin (1 mM), as described in "preparation of hepatocytes and cell culture", it is believed that Ca 2ϩ level in hepatocytes might be increased by the activation of insulin in the presence of exogenous CaCl 2 . [21] [22] [23] It is inferred that exogenous CaCl 2 might be used as a source of hepatocellular Ca 2ϩ , and might increase MTP activity.
MTP activity (3639Ϯ107 nM/protein-mg) increased by exogenous CaCl 2 (100 mM) (Fig. 1A) was decreased to 2438Ϯ58 nM/protein-mg by EDTA (2 mM), a Ca 2ϩ chelator ( Fig. 2A) . This suggests that inhibitory effect of EDTA on MTP activity is resulted from blocking the influx of Ca 2ϩ (1.8 mM) in physiological culture medium from outer to intrahepatocytes.
In reality, the association between hepatocellular total Ca 2ϩ level and MTP activity is evident due to the finding that A23187, which increased from control (0.40Ϯ0.01 mM/protein-mg) to 0.90Ϯ0.38 mM/protein-mg intracellular Ca 2ϩ (Fig. 3A) , increased MTP activity ( Fig. 2A) as compared with that in control, in the absence of A23187. This suggests that MTP activity is directly increased by A23187-elevated intracellular total Ca 2ϩ (0.90Ϯ0.38 mM/protein-mg) from control Ca 2ϩ (0.40Ϯ0.01 mM/protein-mg). It is known that A23187 as a fluorescent compound produces emission at a single maximum located at 437 nm. 10) As described in "Measurements of MTP activity", since MTP activity was determined by measuring fluorescence at 535 nm, it is thought that the increase of MTP activity by A23187 ( Fig. 2A) is independent on the fluorescence of A23187. At present, it could not explain whether the increase of MTP activity by the treatment of exogenous CaCl 2 or A23187 is due to the increase in MTP synthesis, or in MTP specific activity. Because Ca 2ϩ -dependent neutral protease exists in the liver, 24) it could be inferred that MTP activity might be decreased by the proteolysis of MTP under intracellular Ca 2ϩ -increase. However, since the MTP activity was increased by exogenous CaCl 2 or A23187 (Figs. 1A, 2A) , it is thought that MTP activity increased under the treatment of exogenous CaCl 2 or A23187 is not due to the increase of MTP synthesis in hepatocytes.
It is unfortunate that the precise mobilization-mechanism of Ca 2ϩ activating MTP in hepatocytes is unknown. In the present study, we did not investigate the mechanism of Ca 2ϩ -mobilization. However, it is known that hormone-mediated Ca 2ϩ -signaling is initiated by the agonist-induced activation of phospholipase C, which hydrolyzes phosphatidylinositol 4,5-bisphosphate into two intracellular messengers, inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DG). The ensuring increase in cytosolic free-Ca 2ϩ results in the IP 3 -mediated release of Ca 2ϩ from internal stores and an influx of Ca 2ϩ from external space. 25, 26) DG activates the protein kinase C (C-kinase) with Ca 2ϩ in a synergistic manner. A23187 treatment of hepatocytes is known to produce DG and activate C-kinase. 27) This reflects that A23187 may increase Ca 2ϩ level via the IP 3 -mediated Ca 2ϩ -mobilization. If intracellular Ca 2ϩ has a function of enhancing hepatocellular MTP activity, calmodulin as a Ca 2ϩ receptor would increase its activity by binding with Ca 2ϩ (Fig. 1B) . This is supported by enhanced MTP activity (3447Ϯ85 nM/proteinmg) in the presence of 0.4 mg calmodulin and 100 mM CaCl 2 as compared with that (2649Ϯ202 nM/protein-mg) of control in the absence of exogenous calmodulin and CaCl 2 (Fig. 2B) . At present, this is unclear why the change of MTP activity by calmodulin (0.4 mg) plus CaCl 2 (100 mM) was the same as those of MTP activities with the sole treatment of either 0.4 mg calmodulin or 100 mM CaCl 2 (Fig. 2B) . However, the possibility may be explained with those reports that the simultaneous presence of CaCl 2 (100 mM) and calmodu lin (0.4 mg) was necessary for the half-maximal activation of Ca 2ϩ -dependent phosphodiesterase in the liver. [11] [12] [13] Yamagami and Terayama 13) have also reported that 0.4 mg calmodulin, in the presence of 100 mM CaCl 2 , yielded a maximal activity of phosphodiesterase in both the bovine brain and liver. The MTP activity (2649Ϯ202 nM/protein-mg) observed in control may be a naturally-occurred (or basal) value where hepatocytes contain 0.40Ϯ0.01 mM/protein-mg of total Ca 2ϩ (Fig. 3A) , and the concentrations of calmodulin in all vertebrate cells and tissues are also generally well known as more than 30 mM 30) which possibly be able to derive the level of MTP activity to a maximum. If so, the addition of either the exogenous calmodulin (0.4 mg) or CaCl 2 (100 mM) would not make a difference in MTP activity under those conditions (Figs. 1A, B) . It is inferred that MTP activity was similarly sustained by calmodulin (0.4 mg) (Fig. 1B) , CaCl 2 (100 mM), and calmodulin (0.4 mg) plus CaCl 2 (100 mM) (Fig. 2B) . Ca 2ϩ -binding proteins such as calmodulin and calnexin regulate multiple cellular functions including secretion of biosubstances from cells. 28, 29) It is known that over 30 mM of calmodulin are contained in all vertebrate cell and tissues. 30) If the MTP activity (2649Ϯ202 nM/protein-mg) is a natural activity in hepatocytes containing 30 mM of calmodulin and 0.40Ϯ0.01 mM/protein-mg of total Ca 2ϩ (Fig. 3A) , it is thought that intrahepatocellular calmodulin and Ca 2ϩ may involve in the increase of MTP activity, which is supported from results that MTP activities were increased in the presence of various concentration of CaCl 2 and calmodulin (Figs. 1A, B, Figs. 2A, B) . Calnexin also could participate in the increase of that.
The action mode of Ca 2ϩ -binding protein is accompanied with protein phosphorylation. The effects of downstream targets in Ca 2ϩ signaling are not elucidated in this work, therefore, future work remains to be done on that subject. Since W-7 binds selectively to calmodulin and inhibits the effects of calmodulin, 31) MTP activity increased by the presence of Ca 2ϩ and calmodulin would be decreased by W-7 (Fig. 2B) . Because it is known that C-kinase inhibitor, chelerythrine, suppresses TG-rich VLDL secretion from hepatocytes, 7) it could be anticipated that C-kinase and Ca 2ϩ might induce TG-rich VLDL secretion by activating MTP activity. When hepatocytes (10 6 cells/well) were incubated in the presence of A23187, the amount (95.0Ϯ1.0ϫ10 2 ng/protein-mg) of TG secreted into culture medium was increased versus that (67.0Ϯ0.5ϫ10 2 ng/protein-mg) in the control (Fig. 4A) . These results suggest that the secretion of TG by A23187 might be due to the activation of MTP via the action of C-kinase and Ca 2ϩ . Hypertriglyceridemia and hypercholesterolemia are major risk factors of atherosclerosis, and LDL is recognized as a major atherogenic lipoprotein. 18, [32] [33] [34] On the other hand, HDL or alpha lipoproteins appeared to have an inverse relation to the risk of atherosclerosis. Hepatic TG is secreted into the blood in the form of TG-rich VLDL containing various lipids such as phospholipids, cholesterol, and b-lipoprotein. The secretion of TG-rich VLDL is associated with the occurrence of hypertriglyceridemia, which is mediated by MTP. [1] [2] [3] The level of TG in hepatocyte culture medium was significantly increased by the treatment of A23187 (Fig. 4A) . These results suggest that A23187 is associated with the release of TG, and support that the activation of MTP by the increase of Ca 2ϩ level in hepatocytes may cause the hypertriglyceridemia. Otherwise, MTP activity would not be increased in the presence of A23187 that increased TG level in hepatocyte culture medium (Fig. 4A) and Ca 2ϩ level in hepatocytes (Fig. 3A) .
Furthermore, the level of TG in culture medium increased by the treatment of A23187 was decreased to the level of control in the presence of EDTA (Fig. 4A) . The level of TC that released from hepatocytes to the culture medium in response to A23187, although it was statistically insignificant, was increased numerically up to 36Ϯ1.0ϫ10 2 ng/protein-mg compare to the control level of TC (34Ϯ1.0ϫ10 2 ng/proteinmg) where a mixture of both A23187 and EDTA decreased the TC level to 25Ϯ3.0ϫ10 2 ng/protein-mg (Fig. 4B) . Similarly, the TG release from hepatocytes to culture medium was increased by A23187 and was significantly decreased by A23187 with EDTA (Fig. 4A) . In other words, if A23187, as this has been found to stimulate the MTP activity and Ca 2ϩ level in hepatocytes, also stimulated the release of both TG and TC, the decreased response of hepatocellular Ca 2ϩ level by A23187 with EDTA (Fig. 3A) may reduce the activity of MTP ( Fig. 2A) and that could inhibit the release of both TG and TC (Figs. 4A, B) . Moreover, the increased Ca 2ϩ in response to A23187 could also cause hypertriglyceridemia by increasing the MTP activity. A strong evidence for that could be the decrease of hepatocellular Ca 2ϩ in response to EDTA, a Ca 2ϩ chelator (Fig. 3A) , thus the reduction of MTP activity may relate to the inhibition of hypertriglyceridemia (Fig.  4A) . This reflects that Ca 2ϩ antagonists inhibit the secretion of TG-rich VLDL from rat hepatocytes. [4] [5] [6] Because the secretion of TG was increased from hepatocytes to culture medium by A23187 that increased MTP activity (Figs. 2A,  4A) , it is thought that the activated MTP results in a decrease in TG level in hepatocytes.
However, it was not decreased but was sustained at a high level in hepatocytes treated with A23187 as compared with that of control, in the absence of A23187 and EDTA (Fig.  3B) . These are in accord with the facts that Ca 2ϩ and A23187 activate the synthesis of hepatocellular TG, 8, 19) MTP activity increases due to an increased TG level in hepatocytes, 4) and MTP-mediated TG transport increases with increasing intracellular TG level. 35) Hypertriglyceridemia was arised to 41.8% of control by treatment with A23187 ( Fig. 4A ) with significant increase in the ratio of TG to HDL-cholesterol creating an atherogenic risk (Fig. 4D) . The ratio of TG to HDL-cholesterol was increased to 65.4% (Fig. 4D) , and was decreased by treatment with EDTA (Fig. 4D) . Because the inhibition of MTP activity results in decreasing of VLDL secretion, it is nature that the levels of TG, cholesterol, and b-lipoprotein containing in VLDL would be decreased in hepatocytes culture medium or blood. Our findings demonstrate that hypertriglyceridemia and hypercholesterolemia might be inhibited by suppressing MTP activity via the inhibition of hepatocellular Ca 2ϩ -elevation, which may reduce the risk of atherogenesis.
